PTJ
XBIT icon

Paul Tudor Jones’s XBiotech XBIT Stock Holding History

Paul Tudor Jones’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,543
Closed -$103K – 1371
2019
Q2 		$103K Sell
13,543
-1,949
-13% -$17K ﹤0.01% 1027
2019
Q1 		$171K Sell
15,492
-5,726
-27% -$46.4K 0.01% 1018
2018
Q4 		$108K Hold
21,218
– – ﹤0.01% 922
2018
Q3 		$67K Hold
21,218
– – ﹤0.01% 1041
2018
Q2 		$95K Hold
21,218
– – ﹤0.01% 985
2018
Q1 		$114K Hold
21,218
– – ﹤0.01% 917
2017
Q4 		$84K Hold
21,218
– – ﹤0.01% 1033
2017
Q3 		$93K Buy
21,218
+7,166
+51% +$33.8K ﹤0.01% 1017
2017
Q2 		$66K Buy
+14,052
New +$135K ﹤0.01% 975

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Paul Tudor Jones's XBIT Position: Q3 2019 in Review

Paul Tudor Jones sold out of XBiotech (XBIT) in Q3 2019, closing a stake of 13,543 shares — an estimated $103K sold.

Paul Tudor Jones first reported a position in XBIT in Q2 2017 and held it in 9 quarters. The position peaked at $171K in Q1 2019. 47 funds tracked by Wall St. Rank hold XBIT as of Q3 2019.

  • Paul Tudor Jones reported no remaining XBiotech position as of Q3 2019 after selling out during the quarter.
  • Paul Tudor Jones sold 13,543 XBiotech shares in Q3 2019, an estimated $103K.
  • Paul Tudor Jones first reported a position in XBiotech in Q2 2017 and held it in 9 quarters.
  • Paul Tudor Jones's XBiotech position peaked at $171K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held XBiotech as of Q3 2019.

Based on Tudor Investment Corp's 13F filing for Q3 2019, filed 14 Nov 2019.